Crossmark

Anti-thrombotic and glucose lowering therapy in diabetic patients with coronary artery disease undergoing PCI with stent implantation: A prospective multicenter observational study on prescription patterns and clinical outcomes. Baseline inclusion data of the ARTHEMIS registry

Crossref DOI link: https://doi.org/10.1016/j.repc.2025.03.006

Published Print: 2025-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bravo Baptista, Sérgio

Pires de Morais, Gustavo

Almeida Morais, Luís

Costa, João

Vinhas, Hugo

Campos, Gustavo

Carrilho Ferreira, Pedro

Vale, Nélson

Seixo, Filipe

Santos, Miguel

Martins, Cristina

Rodrigues Brás, Diogo

Alexandre, André

Raposo, Luís
Funding

Funding for this research was provided by:

AstraZeneca PLC
License Information

Text and Data Mining valid from 2025-09-01

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-07-26
More Information

This article is maintained by: Elsevier

Article Title: Anti-thrombotic and glucose lowering therapy in diabetic patients with coronary artery disease undergoing PCI with stent implantation: A prospective multicenter observational study on prescription patterns and clinical outcomes. Baseline inclusion data of the ARTHEMIS registry

Journal Title: Revista Portuguesa de Cardiologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.repc.2025.03.006

Content Type: article

Copyright: © 2025 Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below